Expression of the immune checkpoint protein programmed cell death 1 ligand 1 (PD-L1) has been observed in patients with CML, particularly in patients classified as high risk by Sokal score [104]. The gene discussed is CD274; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.